Posaconazole as first line treatment for disseminated zygomycosis.

Abstract	We describe the first case report of posaconazole use as first line agent in the treatment of disseminated zygomycosis with prosthetic hip joint and pulmonary involvement due to Rhizopus microsporus. This infection occurred in a heavily immunosuppressed patient with systemic lupus erythematosus.
Authors	Trisha Peel, John Daffy, Karin Thursky, Peter Stanley, Kirsty Buising
Journal	Mycoses (Mycoses) Vol. 51 Issue 6 Pg. 542-5 (Nov 2008) ISSN: 1439-0507 [Electronic] Germany
PMID	18422921 (Publication Type: Case Reports, Letter)
Chemical References	Antifungal Agents Triazoles posaconazole
Topics	Antifungal Agents (therapeutic use) Female Hip Prosthesis Humans Immunocompromised Host Lung Diseases, Fungal (drug therapy) Lupus Erythematosus, Systemic (complications) Middle Aged Prosthesis-Related Infections (drug therapy) Rhizopus (isolation & purification) Triazoles (therapeutic use) Zygomycosis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!